Fri, 12 Apr 2019 16:51:16 GMT
Bristol-Myers shareholders seek Celgene takeover approval
On Friday, Bristol-Myers Squibb's shareholders voted for approval of the drugmaker's $74.0B takeover of the biotech company Celgene Corp, despite Starboard Value's intention to scrap the deal.